How is liquid biopsy revolutionizing cancer diagnosis and monitoring?
Liquid biopsy is an innovative technique that involves analyzing circulating tumor DNA (ctDNA) in a patient's blood. This non-invasive method allows for early detection of cancer, monitoring of disease progression, and assessment of treatment response. Liquid biopsy can provide real-time insights into the genetic alterations of tumors, facilitating more precise and timely interventions.
